Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma
NCT00456716Phase 2Completed
- Sponsor
- Swedish Health Services
- Start
- Mar 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in lung adenocarcinoma (LUAD), bronchioloalveolar carcinoma (BAC), sponsored by Swedish Health Services. Started Mar 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
lung adenocarcinoma (LUAD)bronchioloalveolar carcinoma (BAC)
Beyond the preview
Go deeper on NCT00456716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456716.